Cardiology consult
CONSULT · Dr. R. Patel · Mar 7, 2026, 7:15 AM
Inferior STEMI. Troponin trending 2.1 to 8.4. Dual antiplatelet therapy initiated (aspirin + clopidogrel). Recommend emergent cath.
Attending Physician
Active Chart · MRN SYN-1004
71 y/o M · ST-elevation myocardial infarction
Encounter timeline and laboratory review
Linked visit history and responsible clinicians.
ST-elevation myocardial infarction · Dr. Carla Vega
Started Mar 7, 2026, 6:20 AM
Recent resulted values for the active encounter.
| Collected | Test | Value | Reference |
|---|---|---|---|
| Mar 7, 2026, 7:00 AM | BNP | 890 pg/mL | <100 |
| Mar 7, 2026, 7:00 AM | CK-MB | 42 U/L | 0-7 |
| Mar 7, 2026, 7:00 AM | Troponin I | 8.4 ng/mL | <0.04 |
| Mar 7, 2026, 6:30 AM | Creatinine | 1.1 mg/dL | 0.7-1.3 |
| Mar 7, 2026, 6:30 AM | Troponin I | 2.1 ng/mL | <0.04 |
CONSULT · Dr. R. Patel · Mar 7, 2026, 7:15 AM
Inferior STEMI. Troponin trending 2.1 to 8.4. Dual antiplatelet therapy initiated (aspirin + clopidogrel). Recommend emergent cath.
Progress and clinical documentation
CONSULT · Dr. R. Patel · Mar 7, 2026, 7:15 AM
Inferior STEMI. Troponin trending 2.1 to 8.4. Dual antiplatelet therapy initiated (aspirin + clopidogrel). Recommend emergent cath.
Medication, lab, and imaging entry
LAB · Mar 7, 2026, 6:25 AM
Parameters: q6h
Rationale: Trend cardiac biomarkers.
LAB · Mar 7, 2026, 6:25 AM
Parameters: stat
Rationale: Evaluate ST changes.
Finalize documentation and orders
Signing this visit finalizes notes and promotes all remaining draft or pending orders to signed.